comparemela.com
  1. Home
  2. Live Updates
  3. Prnewswire Gracell Biotechnologies Inc - Breaking News

Latest Breaking News On - Prnewswire gracell biotechnologies inc - Page 1 : comparemela.com

Gracell Biotechnologies Announces Up to $150 Million Private Placement Financing Joined by a Syndicate of Premier Healthcare Investors

/PRNewswire/ Gracell Biotechnologies Inc. ("Gracell" or the "Company", Nasdaq: GRCL), a global clinical-stage biopharmaceutical company dedicated to.

United statesMarvin tangJessica laubStephanie carringtonWilliam wei caoCompany the ordinaryExchange commissionCompany americanPivotal life sciencesPrnewswire gracell biotechnologies incGracell biotechnologies incVivo capitalAdage capital partnersExome asset managementJanus henderson investorsLogos capital

Gracell Biotechnologies Presents Updated Data of Deep and Durable Responses for FasTCAR-T GC012F in Relapsed/Refractory Multiple Myeloma at 2023 ASCO Annual Meeting

/PRNewswire/ Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to.

United statesJessica laubWendy liStephanie carringtonMarvin tangFierce life sciences innovationExchange commissionAmerican society of clinical oncologyGracell biotechnologies incPrnewswire gracell biotechnologies incClinical oncologyChief medical officerEuropean hematologyHematologic malignanciesChronic lymphocytic leukemiaInvestigational new drug

Gracell Biotechnologies Presents Updated Data of Deep and Durable Responses for FasTCAR-T GC012F in Relapsed/Refractory Multiple Myeloma at 2023 ASCO Annual Meeting

Gracell Biotechnologies Presents Updated Data of Deep and Durable Responses for FasTCAR-T GC012F in Relapsed/Refractory Multiple Myeloma at 2023 ASCO Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJessica laubWendy liMarvin tangStephanie carringtonGracell biotechnologies incFierce life sciences innovationAmerican society of clinical oncologyPrnewswire gracell biotechnologies incExchange commissionClinical oncologyChief medical officerEuropean hematologyHematologic malignanciesChronic lymphocytic leukemiaInvestigational new drug

Gracell Biotechnologies to Present Updated Clinical Data on BCMA/CD19 Dual-Targeting FasTCAR-T GC012F at 2023 ASCO Annual Meeting

/PRNewswire/ Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to.

United statesGracell fasStephanie carringtonMarvin tangKyle evansWendy liGracell biotechnologies incExchange commissionAmerican society of clinical oncologyFierce life sciences innovationPrnewswire gracell biotechnologies incClinical oncologyAnnual meetingChief medicalInvestigational new drugHematologic malignancies

Gracell Biotechnologies to Participate in Oppenheimer 33rd Annual Healthcare Conference

/PRNewswire/ Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell" or the "Company"), a global clinical-stage biopharmaceutical company dedicated to.

Marvin tangPrnewswire gracell biotechnologies incGracell biotechnologies incAnnual healthcare conferenceGracell biotechnologies inc

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.